Hepatitis B virus (HBV) X protein activates many viral and cellular genes in trans and functional disruption of the p53 tumor suppressor gene product occurs when X protein is transiently expressed in the cytoplasm of cultured cells. We have carried out investigations to determine the exact location of X protein in X gene transfected cells by using a¯uorescent staining technique as well as by biochemical analyses. Aggregation of mitochondrial structures became evident at the periphery of nucleus in the cytoplasm of X transfected cells. X protein was found associated with the aggregated mitochondrial structures. Furthermore, transiently expressed p53 protein co-localized with X protein in X transfected cells. However, the appearance of aggregated mitochondrial structures at the nuclear periphery was independent of the presence of p53 protein in X transfected cells. X protein expression also caused an appearance of TUNEL positive nucleus, cytochrome c release from mitochondrial, the decrease of mitochondrial membrane potential and the membrane blebbing of X transfected cells, which are characteristic of cell death. Our data suggest that X protein causes an abnormal aggregation of mitochondrial structures in the cell, which may be eventually connected with cell death.
Introduction
Hepatitis B virus (HBV) is closely associated with acute or chronic hepatitis as well as the development of hepatocellular carcinoma (HCC) (for review, see Ganem and Varmus, 1987; Tiollais et al., 1985) . One of the HBV genes, X, encodes a basic protein of 154 amino acids, which has been implicated in the carcinogenicity of this virus as a potential causative factor because of its ability to induce transformation of rodent cells (Hohne et al., 1990; Rakotomahanina et al., 1994; Shirakata et al., 1989) and to cause the development of HCC in transgenic mice (Kim et al., 1991) . The X gene product is also known to transactivate a number of viral and cellular genes (Spandau and Lee, 1998 ; for review Rossner, 1992) . In recent years, the transactivation function of X protein has been extensively studied by many investigators. Some reports suggested that X protein transactivates transcription via protein-protein interaction with cellular factors that bind to their recognition sequences (Maguire et al., 1991; Natoli et al., 1994a) . Some other reports suggested a possible role of X protein in the regulation of signal transduction pathways (Benn and Schneider, 1994; Cross et al., 1993; Kekule et al., 1993; Natoli et al., 1994b) . In addition, a Kunitz inhibitor (KI) domain-like region was shown to be indispensable for the transactivation function of X protein Takada and Koike, 1990) .
It is known that normal and most p53 mutant proteins are located in the nucleus (Shaulsky et al., 1991) , whereas X protein is found in the cytoplasm around the nuclear periphery (Benn and Schneider, 1994) . In our previous study, we demonstrated that the X protein changed the location of transiently expressed or endogenous p53 protein from the nucleus to the cytoplasm and was found associated with the aggregated structures in the cytoplasm (Takada et al., 1997) . This change was shown to be dependent on a direct or indirect interaction between the carboxyterminal region of p53 protein and the transcriptional activation domain (KI domain-like region) of X protein. Furthermore p53-independent cell death caused by X protein expression has been recently reported (Terradillos et al., 1998) . However, the exact location of X protein in the cytoplasm and a physiological consequence of cytoplasmic localization with respect to the organelle structures remains to be demonstrated.
We studied here the precise location of X protein using¯uorescent staining and biochemical analyses. Results demonstrated that X protein is associated with abnormally aggregated mitochondrial structures around the nuclear periphery. Consistent with our previous results, transiently expressed p53 protein was found to co-localize with X protein in cells transfected with X gene. However, the aggregation of mitochondrial structures around the nuclear periphery was p53-independent. Therewith, we carried out a series of cytochemical studies on the cell and mitochondrial structures in X transfected cell to reveal whether there is any characteristic change of cell death. Results imply that the presence of X protein causes a concomitant change in the mitochondrial structure and function in a p53-independent manner and in so doing, X protein may eventually induce mitochondria-related cell death.
Results

Expression of HBV X protein after transfection of X or its mutant genes
Western blot analysis was carried out using U23 antibody to determine the protein expression levels of the wild-type X gene (pCMVX) and three mutants of the X gene (pCMVX-dAvaI/AvaI, pCMVX-dAvaI/ AvaII and pCMVX-DRsaI) in transfected HepG2 and/or HuH7 cells ( Figure 1A ). Mutant dAvaI/AvaI has lost a portion of the N-terminal region, but still retains the transactivation function of X protein (Arii et al., 1992) . The deletion mutant dAvaI/AvaII further lost the N-terminal region than dAvaI/AvaI, and contains only a part of the KI domain-like sequence. The truncated mutant DRsaI lost a part of the Cterminal region, which is necessary for transactivation function of X protein. As shown in Figure 1B , the expressed level of dAvaI/AvaI protein was slightly lower when compared to the level of wild-type X protein (lanes 3 and 2 of the panels a and b, respectively). The expression level of mutant pCMVX-dAvaI/AvaII (lane 4 of the panels a and b) was signi®cantly lower than the wild-type. When HepG2 cells were transfected with the same set of X expression plasmids and the levels of expressed protein were again analysed with the X3 antibody, wild-type X protein was detected as before (lane 2 of the panel c), however, mutant dAvaI/AvaI or dAvaI/AvaII protein was not detected by the X3 antibody (lane 3 or 4 of the panel c, respectively). The X3 antibody is speci®c for the N-terminal region of X protein where mutant dAvaI/AvaI or dAvaI/AvaII has a deletion. On the other hand, the mutant DRsaI protein was detected (lane 3 of the panel d). Double staining of X protein and mitochondria in X gene-transfected cells
To investigate the nature of aggregated cytoplasmic structures in X expressing cells, X transfected cells were subjected to¯uorescent double staining. Staining of X protein with the Texas Red-labeled antibody coincided with the appearance of dense structures at the nuclear periphery (Figure 2d,g ) under phase-contrast microscopy, whereas these structures were absent in the control cells (Figure 2a) . We also stained untransfected ( Figure 2c ) and X transfected cells (Figure 2f ) with a mitochondria-speci®c staining agent, MitoTracker TM . Aggregated mitochondrial structures were only observed in X transfected cells (Figure 2f ), in comparison with the dispersed staining of mitochondria in the cytoplasm of untransfected cells (Figure 2c ). Double staining of X protein and mitochondria revealed a staining pattern consistent with the presence of X protein with the abnormally aggregated mitochondrial structures (Figure 2e,f) .
To con®rm the co-localization of X protein with the aggregated mitochondrial structures,¯uorescent double-staining experiments were carried out using a combination of anti-X antibody and anti-cytochrome oxidase (COX) antibody. The location of X protein was coincided with that of the COX protein ( Figure  2h ,i, respectively). When X expressing cells were probed with a bcl-2 speci®c antibody, a weak but signi®cant bcl-2 staining was also observed in the aggregated mitochondrial structures (data not shown).
To further con®rm the above observations, doublestained samples were subjected to confocal microscopy inspection. Interestingly, the distribution of X protein Figure 3b ) coincided with that of the mitochondria (green color in Figure 3c ). A colocalization is presented by yellow color (Figure 3d ). However, mitochondria were also distributed somewhat in the other area of cytoplasm than the X protein staining. In addition X protein was occasionally observed in the nuclear region as aggregated structures by the Texas Red-labeled antibody (Figures 2e and 3b) . However, these structures were also stained by the mitochondria-speci®c dye (Figures 2f and 3c ), raising the possibility that the small amount of X protein stained in the nuclear region was most probably due to the non-speci®c attachment of abnormally aggregated mitochondrial structures to the nuclear surface.
We next investigated the structural region of X protein that is responsible for its association with mitochondria. Firstly, the eect of the dAvaI/AvaI mutant on the distribution of mitochondria was examined. Mutant dAvaI/AvaI was able to induce the aggregation of mitochondrial structures (Figure 4a±c ), as was seen in the cells that were transfected with the wild-type X gene (Figure 2d ± f). We also examined mutant DRsaI, that is unable to function as a transactivator nor to induce the cytoplasmic retention of the p53 protein (Takada et al., 1997) . As shown in Figure 4d ± f, mutant DRsaI had the capacity to induce the aggregation of mitochondrial structures. This strongly suggested that there is a functional distinction between the appearance of aggregated mitochondria and transactivation in X expressing cells.
In our previous study, we demonstrated that the expression of X protein changes the location of the p53 protein from the nucleus to the cytoplasm (Takada et al., 1997) . We tried to see the location of the X and Figure 5d clearly demonstrates the co-localization of p53 protein with X protein, presented as a yellow color. Although the expression of X protein resulted in the appearance of aggregated mitochondrial structures in the cytoplasm, p53 expression alone gave no such change in the distribution of mitochondria as assessed by the MitoTracker TM staining described later.
The presence of X protein in the isolated mitochondria fraction
We then tried to demonstrate the presence of X protein in the mitochondria fraction by biochemical analysis. HepG2 cells were transfected with the X gene expression plasmid, harvested 2 days post transfection and homogenized, and whole cell homogenates were subjected to subcellular fractionation. The nuclear or mitochondria fraction and post-mitochondrial fraction as well as the whole homogenate thus obtained were subjected to the Western blot analysis. X protein was detected in the whole cell homogenate and in the mitochondria fraction ( Figure 6a , lanes 2 and 4, respectively), indicating that X protein was associated only with mitochondria. X protein was not detected in the post-mitochondrial (lane 3) nor nuclear fraction (lane 5). It is worthy to note that because X protein was not detected in the post-mitochondrial fraction, X protein was absent in the endoplasmic reticulum and soluble fractions. Distribution of mitochondria-speci®c 60K protein coincided with that of X protein in the analysis (Figure 6b ). In addition, a signi®cant amount of p53 protein was detected in the mitochondria fraction in cells co-transfected with X and p53 genes, but not in X untransfected cells (data not shown).
Aggregation of mitochondria in the absence of p53 protein
To determine if the appearance of aggregated mitochondrial structures was dependent on the presence of p53 protein, Saos-2 cells that do not express p53 protein were used as a recipient of the X gene transfection. Aggregated mitochondrial structure and X protein were observed at the nuclear periphery (Figure 7a ± c). Saos-2 cells were stained with MitoTracker TM dye to examine the distribution of mitochondria in untransfected cytoplasm. Consistent with the above observation, aggregated mitochondrial structures were found at the nuclear periphery of X expressing cells (Figure 7b ), whereas mitochondria in untransfected cells were dispersely located in the cytoplasm (Figure 7e ). This clearly indicated that the appearance of abnormally aggregated mitochondrial structures around the nuclear periphery was dependent on the presence of X protein but was not dependent on the presence of the p53 protein.
Cell death as a physiological consequence of X protein expression
It is accepted that unique characteristics in mitochondria-related cell death are an appearance of TUNEL positive nucleus, the membrane blebbing cell, the decrease of mitochondrial membrane potential and cytochrome c release from mitochondria. Following experiments were carried out to reveal whether there is any characteristic change of cell death by X protein. When the X transfected HuH7 cells were examined by the TUNEL method, we observed a clear nuclear staining because of the DNA breakage only in the X expressing cell (Figure 8b ,c) in contrast to the surrounding non-expressing cell (Figure 8a ), supporting the previous observation in X transgenic mice (Terradillos et al., 1998) . We then directly examined a morphological change of X expressing cells transfected with GFP-X fusion gene without staining and observed expressed GFP-X fusion proteins at the nuclear periphery as aggregated structures (Figure 8d ,e), similar to the case transfected with X gene as indicated above (Figure 2 ). During the prolonged incubation, the cell morphology was only changed in an X expressing cell ( Figure  8d ,e), as indicated by the blebbing of membrane structure (presented by the upper left cell in Figure  8d ), which is a typical change in the apoptotic cell. However, when we examined the nuclear structure in X expressing cell, there was rather slower morphological change of the nuclear structure (presented by the lower right cell in Figure 8d ) as compared to that of drug-induced apoptosis in general (Petit et al., 1996) . Furthermore, we examined the mitochondrial membrane potential by the JC-1 staining method. As a result, Figure 8h shows loss of both orange (energized state) and green (de-energized state) colors of aggregated mitochondria in the X expressing cell as compared to the surrounding non-expressing cells (Figure 8g ,f, respectively), indicating that the membrane potential of X expressing cell was extremely decreased. X transfected HuH7 cells were also subjected to immuno¯uorescent double staining with Texas Red-labeled X antibody and anti-cytochrome c antibody. Two days post transfection loss of cytochrome c staining (indicated by the arrow in Figure 8k ) coincided with X protein (Figure 8j ) on the aggregated mitochondrial structures (Figure 8i ), suggesting a possibility that cytochrome c may be released from the aggregated mitochondria in the X expressing cells. We also examined the mitochondria aggregation by X protein expression in the presence of nocodazole, which is able to dissociate the alpha-tubulin protein (Tanaka et al., 1998) . X-mediated mitochondria aggregation is still observed even in the presence of nocodazole (data not shown). The X-mediated mitochondria aggregation is, therefore, distinct from the eect of kif 5B inhibition on the mitochondria motility along the alpha-tubulin.
Discussion
By¯uorescent double staining of X protein and mitochondria, the distribution of X protein was found coincided with that of mitochondria in the dense structures at the nuclear periphery in the cytoplasm of the X transfected cell. Unusual dense structures observed in the¯uorescent staining showed clear accordance with those observed in phase-contrast microscopy and was identi®ed as aggregated mitochondria. Confocal microscopy analysis also demonstrated the co-localization of X protein with mitochondria around the nuclear periphery. Appearance of aggregated structure was dependent on the expression of X protein but irrespective of whether p53 protein was present or absent. These structures were not observed in the control non-expressing cells, where the distribution of mitochondria was dispersed in the cytoplasm. It is not known yet, however, how the present observations relate to dynamic mechanism of mitochondria in its morphology and distribution (reviewed by Yae, 1999) or mitochondria-related cell death (Vander Heiden et al., 1997) .
After subcellular fractionation of nuclei, mitochondria and post-mitochondrial supernatant by cell homogenization and dierential and sucrose zone centrifugations, X protein was recovered in the mitochondrial fraction but not in the post-mitochon- Figure 8 X protein expression causes cell death. In the ®rst horizontal panel, HuH7 cells were transfected with HA-tagged X expression plasmid (pCMV-HA-X) and subjected to TUNEL assay. Phase contrast micrograph (a), X protein visualized with anti-HA antibody (b) and TUNEL positive nucleus (c) are presented. In the second horizontal panel, morphological changes after X gene expression are presented, where HuH7 cells were transfected with GFP-tagged X expression plasmid. Phase contrast micrograph (d), and overlay of phase contrast microscopic and¯uorescence images (e) are shown. X protein-expressing cells exhibit mitochondria aggregation and the membrane blebbing. In the third horizontal panel, HuH7 cells were transfected with BFP-tagged X plasmid, stained with JC-1 dye and living cells were examined under¯uorescence microscopy. Phase contrast micrograph (f), X protein (BFP-X) expression (g), JC-1 staining (h) are presented. Low or high membrane potential of mitochondria is shown by green or orange¯uorescence, respectively. In the fourth horizontal panel, mitochondria were stained with MitoTracker 1 dye (Molecular Probes) (i) and X protein with X antibody (j). Cytochrome c was stained with anti-cytochrome c antibody, where absence of cytochrome c is shown by arrow (k). Bars in phase contrast micrographs represent 10 mm. Arrowheads indicate the center of the nucleus drial nor nuclear fractions. It should be noted that in dierential centrifugation of X-non-expressing cells, mitochondria was recovered in the post-nuclear supernatant, while in X-expressing cells mitochondria with X protein was found precipitated with nuclear fraction, suggesting the increased mass (aggregation) of mitochondria. Therefore, we performed sucrose zone centrifugation to separate mitochondria from the nucleus by their dierence in buoyant density.
It is evident from the present data that the distribution of X protein was found in the mitochondria fraction, however, further investigation is required to determine the precise location of X protein in the mitochondria, whether it is located on the outer or inner membrane of the mitochondria. Recently, bcl-2 protein was found localized in the outer membrane of the mitochondria and was shown to inhibit mitochondria-mediated apoptosis (Reed, 1997). It would be interesting to see if there is any direct interaction of X protein with the bcl-2 protein or any, if there is, competition between these two proteins for binding to the same site on the mitochondria surface. The previous and present data showing that X protein expression induces the cytoplasmic retention of p53 protein (Takada et al., 1997) as well as the colocalization of the p53 protein with X protein in the aggregated mitochondrial structures, con®rm the cytoplasmic retention of the p53 protein by X.
All the data so far obtained to clarify an outcome of mitochondrial aggregation in X expressing cells support the previous indication that the cell death is a physiological consequence of X protein expression, but is independent of transactivation function of X protein or the presence of p53 protein. Collectively, it seems evident that X protein causes a change in the mitochondrial structure and function, which is independent of transactivation by X protein. The abnormal mitochondrial aggregation may be promoted by binding of X protein to the mitochondria surface. Unlike the apoptotic event without aggregation of mitochondria structures, abnormal mitochondria aggregation may be a unique event in X proteinmediated cell death. Accumulating data suggest a potential role of X protein to function as a cytotoxic agent that promotes mitochondria-related cell death in the HBV-infected liver actively replicating virus. This X protein-mediated cell death may not only induce tissue regeneration in the infected liver, but also potentially increase a faulty DNA repair connecting to malignant transformation.
Materials and methods
Plasmid DNAs
X gene expression plasmids of wild-type (pCMVX) or three mutants pCMVX-dAvaI/AvaI, pCMVX-dAvaI/AvaII and pCMV-DRsaI, were constructed replacing the b-galactosidase gene of an expression plasmid pCMBb (CLONTECH) by the X ORF or mutant X ORFs of dAvaI/AvaI, dAvaI/ AvaII and DRsaI (Arii et al., 1992) and were driven under the control of a CMV promoter (Kim et al., 1990) . DRsaI has a truncation in the C-terminal region from amino acids 134 to the C-terminus. Deletion mutants, dAvaI/AvaI and dAvaI/ AvaII lack the N-terminal regions from amino acids 5 ± 27 and 5 ± 62, respectively. The HA epitope was added at the Nterminus of X ORF and cloned into pCMV vector, to make pCMV-HA-X. The p53 expression plasmid, pCMVp53, was constructed by replacing b-galactosidase gene of pCMBb (CLONTECH) with a p53 ORF. Coding regions of all the constructs were con®rmed by sequence analysis.
Cell lines and DNA transfection
HepG2 and HuH7 cell lines derived from human hepatoblastoma and human HCC, respectively, are negative for integrated HBV DNA and HBV infection (Takada et al., 1997) . These hepatoma cells are maintained in DM-160AU supplemented with 10% calf serum and 60 mg/ml kanamycin then used as recipients of DNA transfection as described (Takada et al., 1997) . Cells were plated at a density of 3610 6 /100 mm dish for 24 h before transfection and further incubated for 6 h at 378C with DNA precipitates made by the calcium phosphate method using 10 mg of each plasmid DNA. Saos-2 cell is a human osteosarcoma cell line which lacks endogenous p53 (Masuda et al., 1987) . Cells were cultured for 2 days after transfection and subjected to staining or other analyses unless otherwise stated.
Western blot analysis
Western blot analysis was carried out as described (Sambrook et al., 1989) in a 12.5% SDS polyacrylamide gel. The separated proteins were transferred electrophoretically onto an Immobilon membrane (Millipore), probed with antibodies and visualized by ECL immunodetection (Amersham) following the manufacturer's instructions. Rabbit anti-X peptide polyclonal antibodies U23 and X3 were raised by injecting rabbits with oligopeptides corresponding to amino acids 82 ± 100 and 19 ± 35 of X protein, respectively. Monoclonal antibody for mouse anti-human mitochondria 60K protein (CalbiochemNovabiochem) was employed in the biochemical study.
Mitochondria staining and immuno¯uorescent staining of cells
Cells were seeded on a slide¯ask (Nunc) at a density of 3*4610 4 cells/cm 2 and were transfected. Mitochondria were stained with MitoTracker TM or MitoTracker 1 (Molecular Probes) for 60 min following the manufacturer's instructions. The cells were then washed and subjected to immunofluorescent staining as described (Takada et al., 1997) . Primary antibodies of U23 and X3 for X protein, mouse anti-p53 monoclonal antibody PAb 1801 (Oncogene Science), mouse anti-bovine cytochrome oxidase (COX) subunit monoclonal antibody (Molecular Probes) or anti-cytochrome c antibody (Pharmingen) were used. The secondary antibody of Texas Red goat anti-rabbit IgG (Vector Inc.) or¯uoresceinated goat anti-mouse IgG (Oncogene Science) was used as supplied by the manufacturer. More than 10 4 cells were examined microscopically in each slide at a magni®cation of 6200 and at least 100 independent cells were analysed in detail for mitochondrial distribution and the expression of X and/or p53 proteins. Subsequently, about 50 independent phase-contrast and¯uorescent micrographs were taken at the same magni®cation (6200). Confocal microscopic analysis was also carried out using confocal laser microscope LSM410 (Carl Zeiss).
TUNEL assay
For the TUNEL assay, an`in situ cell death detection kit' was used (Boehringer Mannheim). Brie¯y, HuH7 cells were transfected with an HA-tagged X expression plasmid (pCMV-HA-X). Cells on slide were ®xed with freshly prepared paraformaldehyde solution (4% in PBS, pH 7.4) for 30 min at room temperature, rinsed with PBS and incubated in permeabilization solution (0.1% Triton X-100, 0.1% sodium citrate) for 2 min on ice. After rinsing twice with PBS, cells were treated with TUNEL reaction mixture in a humidi®ed chamber for 60 min at 378C in the dark, followed by rinsing three times with PBS. To visualize X protein, cells were incubated with mouse anti-HA mAb (Boehringer Mannheim) (diluted 1:100 in PBS with 3% BSA) followed by incubation with Texas red-conjugated goat antimouse antibody (Southern Biotechnology Associates Inc.) diluted at 1:100. Cells were mounted in antifade medium and analysed with a¯uorescence microscope E600 (Nikon).
Analysis of the cell membrane blebbing and mitochondrial membrane potential Two¯uorescent protein fusion plasmids, pEBFP-X and pEGFP-X, were constructed cloning full length X ORF and BamHI/StyI fragment (amino acids 10 ± 154) into the pEBFP-C1 and the pEGFP-C3 vector (CLONTECH), respectively. These fusion X proteins showed cytoplasmic localization pattern similar to that of intact X protein. HuH7 cells were grown on two chamber slides and transfected with BFPtagged X plasmid (pEGFP-X). Three days post transfection, cells were ®xed with 4% paraformaldehyde solution and analysed under¯uorescence microscopy.
For JC-1 staining, HuH7 cells were grown on two chamber slides (Falcon) and transfected with pEBFP-X. Cells were stained with 10 mg/ml JC-1 (Molecular Probes) in culture medium for 10 min in a cell culture incubator, then rinsed with dye-free culture medium and live cells were analysed under¯uorescence microscopy.
Preparation of subcellular fractions
HepG2 cells at a density of 5610 6 were transfected with X gene expression plasmid, harvested and subjected to subcellular fractionation according to standard procedures using dierential sucrose zone centrifugations (Tanaka and Koike, 1978) , with some minor modi®cations. Cells (Ca. 0.5 g) were homogenized in 5 ml of a Tris buer (10 mM Tris-HCl, pH 8.0, 0.3 M sucrose, 4 mM CaCl 2 ) using motordriven Te¯on pestle and were centrifuged (10 000 r.p.m., 15 min) to separate the post-mitochondrial fraction containing endoplasmic reticulum and cytosol in the supernatant. The pellet was washed once with homogenization buer, resuspended in 5 ml of a Tris buer containing 2 M sucrose and 1 mM CaCl 2 and then loaded on 5 ml of a Tris buer containing 2.2 M sucrose and 1 mM CaCl 2 . After centrifugation at 24 000 r.p.m. for 30 min (Beckmann SW41Ti rotor), the mitochondrial fraction was obtained in the top of 2 M sucrose zone and the nuclear fraction was at the bottom of the tube. The separated mitochondrial and nuclear fractions were each resuspended in a Tris buer containing 0.3 M sucrose, washed, and subjected to dierential centrifugation at 10 000 r.p.m. for 15 min and at 1000 r.p.m. for 10 min, respectively. Each fraction was dissolved in 1 ml of SDScontaining buer and subjected to Western blot analysis. One ml of the post-mitochondrial fraction was mixed with 0.05 ml of 206 SDS-containing buer and an aliquot was also subjected to Western blot analysis.
